Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

Detalles Bibliográficos
Autores principales: Rosario, D J, Bourke, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670490/
https://www.ncbi.nlm.nih.gov/pubmed/23632481
http://dx.doi.org/10.1038/bjc.2013.211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670490/
https://www.ncbi.nlm.nih.gov/pubmed/23632481
http://dx.doi.org/10.1038/bjc.2013.211

Ejemplares similares